Advertisement

#Darzalex

Multiple myeloma cells

Injectable Darzalex Combo Delays Multiple Myeloma Progression

The injectable formulation can cut administration time from two or more hours to just five minutes.

Multiple myeloma cells

FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma

More than 80% of clinical trial participants experienced complete or partial remission.

Darzalex, Darzalex Faspro

FDA Approves Injectable Formulation of Darzalex for Multiple Myeloma

Darzalex Faspro can be given by subcutaneous injection rather than IV infusion.

FDA Approves Darzalex for Transplant-Eligible Multiple Myeloma

The approval is based on data from CASSIOPEIA, an open-label, randomized, active-controlled phase 3 study.

FDA Approves Darzalex (Daratumumab) for Multiple Myeloma

Darzalex in combination with lenalidomide and dexamethasone is for people who are ineligible for an autologous stem cell transplant.

Darzalex for Multiple Myeloma Can Be Injected Subcutaneously

An advanced study compared intravenous infusions and subcutaneous injections of the antibody treatment.

FDA Approves Darzalex Combo for Newly Diagnosed Multiple Myeloma

Four-drug regimen improves response in people being treated for the first time.

Advertisement